UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE
SECURITIES EXCHANGE ACT OF 1934
For the month of March 2018
Commission File Number: 001-36403
IKANG HEALTHCARE GROUP, INC.
(Exact name of registrant as specified in its charter)
B-6F, Shimao Tower
92A Jianguo Road
Chaoyang District, Beijing 100022
People’s Republic of China
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
IKANG HEALTHCARE GROUP, INC. | |
|
|
|
|
|
|
By: |
/s/ YANG CHEN |
|
|
Name: |
Yang Chen |
|
|
Title: |
Chief Financial Officer |
Date: March 28, 2018
Exhibit Index
Exhibit 4.1 — Amendment No. 3 to Rights Agreement, dated as of March 26, 2018, between iKang Healthcare Group, Inc. and American Stock Transfer & Trust Company, L.L.C., as Rights Agent
Exhibit 99.1 — Agreement and Plan of Merger, dated as of March 26, 2018, by and among iKang Healthcare Group, Inc., IK Healthcare Investment Limited and IK Healthcare Merger Limited